Why have you attended Oaksterdam?
Medical marijuana permit applications were announced by the State of Nevada and I found Oaksterdam’s seminar to be everything I needed. As a non-industry person, the seminars gave me the building blocks of information and connections I needed to get where I am today. It all started at Oaksterdam.
How has it helped or inspire you?
As a non-industry person, the seminars gave me the building blocks of information and connections I needed to get where I am today. Our company, Green Therapetuics, has 4 medical marijuana permits in Las Vegas, NV and it all started at Oaksterdam.
What would you tell prospective students?
The content of the seminars are worth it alone. Being an industry person now, Oaksterdam’s reputation means something. Whether you attend the course for personal reasons or have bigger aspirations, being an Oaksterdam means something. We have 4 medical marijuana permits and are looking for future employees. Of course we favor Oaksterdam trained students.
What is the name of your company or business and what services do you provide?
Green Therapeutics is a group of Nevada physicians and pharmacists who have partnered with an expert cannabis cultivator, with the purpose to provide the safest, most consistent, and effective cannabis products. We were awarded with two Cultivation and two Production provisional licenses in facilities with 8,000 and 35,000 square feet, located in Clark County and North Las Vegas. We will produce a full line of products including top-shelf flowers, extracts, and edibles.
Our team’s combination of extensive cannabis cultivation skill and operational medical experience guarantees unsurpassed quality, safety and consistency in our products.
As healthcare professionals, GT understands that there is a patient and symptom behind every dose of medication. This means a maxim that is not solely oriented toward financial metrics, but one that addresses the purpose and spirit of the law – to provide medical cannabis as an alternative to patients with conditions that are not well managed by traditional medicine. We must first and foremost act as patient health advocates. We intend to infuse that maxim in every medicine that we produce.
